TMLCX
Price
$44.16
Change
-$0.02 (-0.05%)
Updated
Jul 13 closing price
Net Assets
4.59B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

TMLCX vs VFFSX

TMLCX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
TMLCX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMLCX is a Hold and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. TMLCX (4.59B). VFFSX pays higher dividends than TMLCX: VFFSX (1.08) vs TMLCX (0.60). TMLCX was incepted earlier than VFFSX: TMLCX (28 years) vs VFFSX (10 years). TMLCX (0.91) is less costly to investors than VFFSX (0.01). TMLCX is a more actively managed with annual turnover of: 14.00 vs. VFFSX (2.00). TMLCX has a lower initial minimum investment than VFFSX: TMLCX (100000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. TMLCX (17.83). VFFSX return over 5 years is better than : 73.48 vs. TMLCX (29.57).
TMLCXVFFSXTMLCX / VFFSX
Total Expense Ratio0.890.018,900%
Annual Report Gross Expense Ratio0.910.019,100%
Fund Existence28 years10 years-
Gain YTD9.19510.68586%
Front LoadN/AN/A-
Min. Initial Investment10000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.59B1.67T0%
Annual Yield % from dividends0.601.0856%
Returns for 1 year17.8321.0785%
Returns for 3 years36.6868.4554%
Returns for 5 years29.5773.4840%
Returns for 10 years137.42251.2155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6